Craig Parker, CEO, Vega Therapeutics
H. Stewart Parker, commercialization advisor, Washington Biotechnology & Biomedical Association
Arleen Paulino, executive director, PD, Amgen
Ray Paxton, research director
Jacques Peschon, senior research scientist, Institute for Systems Biology
Dean Pettit, executive director of process and product development, Amgen
Peggy V. Phillips, board member, Dynavax Technologies
Tom Philpott, service delivery manager, IBM @Amgen [Added: 4:40 pm, 1/4/11]
Kathy Picha, regulatory affairs manager, Dendreon
Nancy Plant, founder and managing member, Adkins, Plant, Elvins & Black
Dave Pon, director of finance, Fred Hutchinson Cancer Research Center
Karen Porter, business system analyst
Mike Preberowsky, independent pharmaceuticals professional
Steven Price, AVP, new products global strategic marketing, ImClone Systems, a subsidiary of Eli Lilly [Added: 12:40 pm, 1/6/11]
Cheryl Purdie, senior drug safety specialist, Human Genome Sciences
Brian Rabinovich, experimental diagnostic imaging group leader, genetic engineering and immunological imaging, UT MD Anderson Cancer Center [Added: 11:38 am, 1/22/11]
Seamus Ragan, scientist, Amgen
Carmen Rahm, assistant vice president for information technology, Central Washington University [Added: 4:40 pm, 1/4/11]
Fred Ramsdell, director, Novo Nordisk
Tom Ranken, president and CEO, Washington Clean Technology Alliance
Janet Rose Rea, clinical assistant professor, University of Washington, and founder, principal consultan, QARA Services [Added: 2:58 pm, 1/3/11]
Judy Rightmire, corporate communications associate, Dendreon
Bill Robertson, cGMP compliance consultant, V2 Bio-Consulting
Chris Rosenau, staffing manager, Microsoft
Eileen Roux, senior manager, Amgen
Timothy Ruane, chief executive officer, InSite Vision [Added: 4:49 pm, 1/4/11]
Abbe Rubin, secretary and treasurer, Sustainable Path Foundation
David Sabritt, president, Sabritt Solutions
William Sargent Jr., vice president of investor relations and communications, Auxilium Pharmaceuticals
Deanna Hill Saxbe, senior associate, Amgen
Nancy Scherer, owner, Altis Medical and Scientific Writing [Updated: 7:40 pm, 1/12/11]
Gordon Schiff, principal database administrator, Amgen
Ann Schmierer, strategic corporate liaison for the Georgia Institute of Technology
Dale Scott, program director, Seattle Genetics
Suzy Scott, owner, A Well Planned Event
Su Searle, corporate facilities maintenance planner/scheduler, Dendreon [Added: 3 pm, 1/13/11]
Kurt Shanebeck, scientist, Allozyne [Added: 12:40 pm, 1/6/11]
